Inaxapline as a potential therapy for APOL1-associated nephropathy
Crossref DOI link: https://doi.org/10.1007/s11560-024-00721-6
Published Online: 2024-03-05
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lang, Konrad
Hermle, Tobias
Text and Data Mining valid from 2024-03-05
Version of Record valid from 2024-03-05
Article History
Accepted: 6 February 2024
First Online: 5 March 2024
Interessenkonflikt
: K. Lang und T. Hermle geben an, dass kein Interessenkonflikt besteht.